These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 23602905)

  • 1. Statistical analysis of big data on pharmacogenomics.
    Fan J; Liu H
    Adv Drug Deliv Rev; 2013 Jun; 65(7):987-1000. PubMed ID: 23602905
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Comparison of Methods for Estimating the Determinant of High-Dimensional Covariance Matrix.
    Hu Z; Dong K; Dai W; Tong T
    Int J Biostat; 2017 Sep; 13(2):. PubMed ID: 28953454
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reducing false positive findings in statistical analysis of pharmacogenomic biomarker studies using high-throughput technologies.
    Matsui S
    Curr Drug Saf; 2006 May; 1(2):135-41. PubMed ID: 18690924
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Big data in pharmacogenomics: current applications, perspectives and pitfalls.
    Barrot CC; Woillard JB; Picard N
    Pharmacogenomics; 2019 Jun; 20(8):609-620. PubMed ID: 31190620
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical trials in pharmacogenetics and pharmacogenomics: methods and applications.
    Rioux PP
    Am J Health Syst Pharm; 2000 May; 57(9):887-98; quiz 899-901. PubMed ID: 10840530
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacogenomics and big genomic data: from lab to clinic and back again.
    Lavertu A; McInnes G; Daneshjou R; Whirl-Carrillo M; Klein TE; Altman RB
    Hum Mol Genet; 2018 May; 27(R1):R72-R78. PubMed ID: 29635477
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Challenges of Big Data Analysis.
    Fan J; Han F; Liu H
    Natl Sci Rev; 2014 Jun; 1(2):293-314. PubMed ID: 25419469
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conference Scene: Lessons learned from the 5th Statistical Analysis Workshop of the Pharmacogenetics Research Network.
    Atkinson EJ; McDonnell SK; Witte JS; Crawford DC; Fan Y; Fridley B; Li D; Li L; Rodin A; Sadee W; Speed T; Weiss ST; Yang J; Yerges L; Schaid DJ
    Pharmacogenomics; 2010 Mar; 11(3):297-303. PubMed ID: 20235785
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An efficient and robust method for analyzing population pharmacokinetic data in genome-wide pharmacogenomic studies: a generalized estimating equation approach.
    Nagashima K; Sato Y; Noma H; Hamada C
    Stat Med; 2013 Nov; 32(27):4838-58. PubMed ID: 23852468
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of DNA microarray data.
    Hackl H; Sanchez Cabo F; Sturn A; Wolkenhauer O; Trajanoski Z
    Curr Top Med Chem; 2004; 4(13):1357-70. PubMed ID: 15379650
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Progress towards the integration of pharmacogenomics in practice.
    Mooney SD
    Hum Genet; 2015 May; 134(5):459-65. PubMed ID: 25238897
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methodological and statistical issues in pharmacogenomics.
    Peters BJ; Rodin AS; de Boer A; Maitland-van der Zee AH
    J Pharm Pharmacol; 2010 Feb; 62(2):161-6. PubMed ID: 20487194
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacogenomics in Pain Management: A Review of Relevant Gene-Drug Associations and Clinical Considerations.
    Brandl E; Halford Z; Clark MD; Herndon C
    Ann Pharmacother; 2021 Dec; 55(12):1486-1501. PubMed ID: 33771051
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methods for analysis in pharmacogenomics: lessons from the Pharmacogenetics Research Network Analysis Group.
    Srinivasan BS; Chen J; Cheng C; Conti D; Duan S; Fridley BL; Gu X; Haines JL; Jorgenson E; Kraja A; Lasky-Su J; Li L; Rodin A; Wang D; Province M; Ritchie MD
    Pharmacogenomics; 2009 Feb; 10(2):243-51. PubMed ID: 19207025
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modeling the genetic etiology of pharmacokinetic-pharmacodynamic links with the ARMA process.
    Lin M; Berg A; Wu R
    J Biopharm Stat; 2010 Mar; 20(2):351-72. PubMed ID: 20309763
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Statistical inference for missing data mechanisms.
    Zhao Y
    Stat Med; 2020 Dec; 39(28):4325-4333. PubMed ID: 32815184
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improving the correlation structure selection approach for generalized estimating equations and balanced longitudinal data.
    Westgate PM
    Stat Med; 2014 Jun; 33(13):2222-37. PubMed ID: 24504841
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Statistical challenges in the analysis of dynamic traits: implications for pharmacogenomic clinics.
    Das K
    Adv Drug Deliv Rev; 2013 Jun; 65(7):973-9. PubMed ID: 23603731
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expected estimating equations for missing data, measurement error, and misclassification, with application to longitudinal nonignorable missing data.
    Wang CY; Huang Y; Chao EC; Jeffcoat MK
    Biometrics; 2008 Mar; 64(1):85-95. PubMed ID: 17608787
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A new estimation with minimum trace of asymptotic covariance matrix for incomplete longitudinal data with a surrogate process.
    Chen B; Qin J
    Stat Med; 2013 Nov; 32(27):4763-80. PubMed ID: 23744541
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.